NAGE · Niagen Bioscience, Inc. · Documents
$2.50
+0.06 (+2.46%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$193.07M
Shares
79.13M
Volume · Oct 27
473.48K
Avg daily vol (3M)
546.87K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-05-06 | — | |
| 10-Q | — | 2021-05-06 | 2021-03-31 | |
| DEF 14A | — | 2021-04-21 | 2021-06-17 | |
| DEFA14A | — | 2021-04-21 | — | |
| S-3 | — | 2021-03-23 | — | |
| 10-K | — | 2021-03-12 | 2020-12-31 | |
| 8-K | — | 2021-03-10 | — | |
| 8-K | — | 2021-02-25 | 2021-02-23 | |
| 8-K | — | 2021-02-22 | 2021-02-20 | |
| 8-K | — | 2020-12-09 | — | |
| 8-K | — | 2020-11-23 | 2020-11-17 | |
| 8-K | — | 2020-11-04 | — | |
| 10-Q | — | 2020-11-04 | 2020-09-30 | |
| 10-Q | — | 2020-08-06 | 2020-06-30 | |
| 8-K | — | 2020-08-06 | — | |
| 8-K | — | 2020-07-08 | 2020-07-06 | |
| 8-K | — | 2020-06-22 | 2020-06-19 | |
| S-3 | — | 2020-06-12 | — | |
| 8-K | — | 2020-05-29 | — | |
| S-3 | — | 2020-05-21 | — | |
| 10-K/A | — | 2020-05-18 | 2019-12-31 | |
| 10-Q | — | 2020-05-18 | 2020-03-31 | |
| NT 10-Q | — | 2020-05-12 | 2020-03-31 | |
| 8-K | — | 2020-05-11 | — | |
| 8-K | — | 2020-05-07 | — | |
| 8-K | — | 2020-04-29 | 2020-04-27 | |
| DEF 14A | — | 2020-04-21 | 2020-06-19 | |
| DEFA14A | — | 2020-04-21 | — | |
| 10-K | — | 2020-03-10 | 2019-12-31 | |
| 8-K | — | 2020-03-10 | — | |
| 8-K | — | 2020-01-10 | 2020-01-07 |
Showing 101–131 of 131 filings
Key facts
CIK
1386570
CUSIP
171077407
13F (30d)
17 filings
16 filers
Visit website
Investor relations